Searched for
EISAI LIMITED
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- Alzheimer disease symptoms treatment: Can Alzheimer's be prevented? Doctors, health experts say yes, prescribe ways to check dementiaWhat makes people more at risk of getting Alzheimer's disease and dementia more broadly? Nearly half of all cases are linked to factors suc...
- Why matcha is trending everywhere: From boosting heart health to weight loss, this over 800-yr-old tea "surprisingly beats" coffee, chai in many waysMatcha, a vibrant green tea powder with ancient Japanese roots, has exploded in popularity worldwide. From traditional tea ceremonies to In...
- Japan's Nikkei closes at 2-week high on tech boostJapan's central bank last month widened the trading band for the benchmark 10-year government bonds to 0.5% from 0.25%, sending yields acro...
- Japan's Nikkei ends at near 3-month low on global recession fearsInvestors globally are on edge as surging borrowing costs stoke fears of widespread recession, with most of the world's major central banks...
- Japan's Nikkei ends higher on economic rebound hopes; Eisai drags TopixThe Nikkei share average ended 0.34 per cent higher at 28,958.56, while the broader Topix ticked down 0.02 per cent to 1,956.73.
- Nikkei slips 0.3% at close; Japan shares end lower on caution ahead of US inflation dataThe Nikkei share average ended 0.35 per cent lower at 28,860.80, while the broader Topix was down 0.28 per cent at 1,957.14.
- Heavyweights pull Nikkei lower, Topix gains on drugmakers' boostNikkei inched down 0.2 per cent to close at 28,963.56, while the Topix edged up 0.1 per cent at 1,962.65.
- Nikkei hits over 2-year high on Wall Street boost, focus on final US election tallyAnalysts said stocks were supported by overnight Wall Street gains as the likelihood of gridlock in Congress made investors optimistic that...
- Japanese shares rebound but spike in COVID-19 cases caps gainsSony Corp added 3.27%, while Yaskawa Electric Corp rose 1.98%.
- Creador frontrunner to buy Tata Capital's stake in packaging coTata Capital to exit its 5-year old investment in Shriji Polymers.
- Keddara, Creador join in race for Tata Capital's stake in Shriji PolymersFinal bids are likely to be submitted by 31 March and the company is expected to be valued at Rs.1000 - 1200 crore, said two people aware o...
- Nikkei falls steepest in 3 months as growth slowdown bitesThe Nikkei share average stumbled 3 per cent to 20,977.11, the lowest since mid-February.
- Nikkei closes flat even as chip makers make a buzzChip equipment makers jumped, tracking a rise in US tech shares overnight.
- Nikkei edges up but gains limited ahead of US-China meetingThe Nikkei share average rose 0.4 per cent to 22,351.06.
- Dr Reddy's may file two new drugs with FDA by 2019The city-based pharma company is expected to file the New Drug Application (NDA)with US Food and Drug Administration with regard the migrai...
- Bulk drugs from China floods Indian market, leaves indigenous products in dire straitsThe Indian bulk drug industry is in dire straits and their prospects appear bleak unless the government takes immediate steps to support th...
- Startups like Waybeo, Dextrasys Tech, ChaYoWo Games & others bloom in small townsA slew of technology startups are making their home in non-metro cities. ET profiles technology product and service startups in non-metro c...
Load More
